Global Tumor Genomics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tumor Genomics Market Size 2017-2028

2.1.2 Tumor Genomics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Tumor Genomics Segment by Type

2.2.1 Assays and Kits

2.2.2 Instrument

2.3 Tumor Genomics Market Size by Type

2.3.1 Tumor Genomics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Tumor Genomics Market Size Market Share by Type (2017-2022)

2.4 Tumor Genomics Segment by Application

2.4.1 Diagnostics and Monitoring

2.4.2 Drug Discovery and Development

2.4.3 Biomarker Discovery

2.5 Tumor Genomics Market Size by Application

2.5.1 Tumor Genomics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Tumor Genomics Market Size Market Share by Application (2017-2022)

3 Tumor Genomics Market Size by Player

3.1 Tumor Genomics Market Size Market Share by Players

3.1.1 Global Tumor Genomics Revenue by Players (2020-2022)

3.1.2 Global Tumor Genomics Revenue Market Share by Players (2020-2022)

3.2 Global Tumor Genomics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Tumor Genomics by Regions

4.1 Tumor Genomics Market Size by Regions (2017-2022)

4.2 Americas Tumor Genomics Market Size Growth (2017-2022)

4.3 APAC Tumor Genomics Market Size Growth (2017-2022)

4.4 Europe Tumor Genomics Market Size Growth (2017-2022)

4.5 Middle East & Africa Tumor Genomics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Tumor Genomics Market Size by Country (2017-2022)

5.2 Americas Tumor Genomics Market Size by Type (2017-2022)

5.3 Americas Tumor Genomics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tumor Genomics Market Size by Region (2017-2022)

6.2 APAC Tumor Genomics Market Size by Type (2017-2022)

6.3 APAC Tumor Genomics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Tumor Genomics by Country (2017-2022)

7.2 Europe Tumor Genomics Market Size by Type (2017-2022)

7.3 Europe Tumor Genomics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tumor Genomics by Region (2017-2022)

8.2 Middle East & Africa Tumor Genomics Market Size by Type (2017-2022)

8.3 Middle East & Africa Tumor Genomics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Tumor Genomics Market Forecast

10.1 Global Tumor Genomics Forecast by Regions (2023-2028)

10.1.1 Global Tumor Genomics Forecast by Regions (2023-2028)

10.1.2 Americas Tumor Genomics Forecast

10.1.3 APAC Tumor Genomics Forecast

10.1.4 Europe Tumor Genomics Forecast

10.1.5 Middle East & Africa Tumor Genomics Forecast

10.2 Americas Tumor Genomics Forecast by Country (2023-2028)

10.2.1 United States Tumor Genomics Market Forecast

10.2.2 Canada Tumor Genomics Market Forecast

10.2.3 Mexico Tumor Genomics Market Forecast

10.2.4 Brazil Tumor Genomics Market Forecast

10.3 APAC Tumor Genomics Forecast by Region (2023-2028)

10.3.1 China Tumor Genomics Market Forecast

10.3.2 Japan Tumor Genomics Market Forecast

10.3.3 Korea Tumor Genomics Market Forecast

10.3.4 Southeast Asia Tumor Genomics Market Forecast

10.3.5 India Tumor Genomics Market Forecast

10.3.6 Australia Tumor Genomics Market Forecast

10.4 Europe Tumor Genomics Forecast by Country (2023-2028)

10.4.1 Germany Tumor Genomics Market Forecast

10.4.2 France Tumor Genomics Market Forecast

10.4.3 UK Tumor Genomics Market Forecast

10.4.4 Italy Tumor Genomics Market Forecast

10.4.5 Russia Tumor Genomics Market Forecast

10.5 Middle East & Africa Tumor Genomics Forecast by Region (2023-2028)

10.5.1 Egypt Tumor Genomics Market Forecast

10.5.2 South Africa Tumor Genomics Market Forecast

10.5.3 Israel Tumor Genomics Market Forecast

10.5.4 Turkey Tumor Genomics Market Forecast

10.5.5 GCC Countries Tumor Genomics Market Forecast

10.6 Global Tumor Genomics Forecast by Type (2023-2028)

10.7 Global Tumor Genomics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Information

11.1.2 Abbott Laboratories Tumor Genomics Product Offered

11.1.3 Abbott Laboratories Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Abbott Laboratories Main Business Overview

11.1.5 Abbott Laboratories Latest Developments

11.2 Agilent Technologies, Inc

11.2.1 Agilent Technologies, Inc Company Information

11.2.2 Agilent Technologies, Inc Tumor Genomics Product Offered

11.2.3 Agilent Technologies, Inc Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Agilent Technologies, Inc Main Business Overview

11.2.5 Agilent Technologies, Inc Latest Developments

11.3 Bio-Rad Laboratories, Inc.

11.3.1 Bio-Rad Laboratories, Inc. Company Information

11.3.2 Bio-Rad Laboratories, Inc. Tumor Genomics Product Offered

11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Bio-Rad Laboratories, Inc. Main Business Overview

11.3.5 Bio-Rad Laboratories, Inc. Latest Developments

11.4 Danaher Corporation

11.4.1 Danaher Corporation Company Information

11.4.2 Danaher Corporation Tumor Genomics Product Offered

11.4.3 Danaher Corporation Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Danaher Corporation Main Business Overview

11.4.5 Danaher Corporation Latest Developments

11.5 F. Hoffmann-La Roche Ltd

11.5.1 F. Hoffmann-La Roche Ltd Company Information

11.5.2 F. Hoffmann-La Roche Ltd Tumor Genomics Product Offered

11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.5.5 F. Hoffmann-La Roche Ltd Latest Developments

11.6 Fluidigm Corporation

11.6.1 Fluidigm Corporation Company Information

11.6.2 Fluidigm Corporation Tumor Genomics Product Offered

11.6.3 Fluidigm Corporation Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Fluidigm Corporation Main Business Overview

11.6.5 Fluidigm Corporation Latest Developments

11.7 General Electric Company

11.7.1 General Electric Company Company Information

11.7.2 General Electric Company Tumor Genomics Product Offered

11.7.3 General Electric Company Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 General Electric Company Main Business Overview

11.7.5 General Electric Company Latest Developments

11.8 Illumina, Inc.

11.8.1 Illumina, Inc. Company Information

11.8.2 Illumina, Inc. Tumor Genomics Product Offered

11.8.3 Illumina, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Illumina, Inc. Main Business Overview

11.8.5 Illumina, Inc. Latest Developments

11.9 Merck KGaA

11.9.1 Merck KGaA Company Information

11.9.2 Merck KGaA Tumor Genomics Product Offered

11.9.3 Merck KGaA Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Merck KGaA Main Business Overview

11.9.5 Merck KGaA Latest Developments

11.10 Myriad Genetics, Inc.

11.10.1 Myriad Genetics, Inc. Company Information

11.10.2 Myriad Genetics, Inc. Tumor Genomics Product Offered

11.10.3 Myriad Genetics, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Myriad Genetics, Inc. Main Business Overview

11.10.5 Myriad Genetics, Inc. Latest Developments

11.11 Pacific Biosciences of California, Inc.

11.11.1 Pacific Biosciences of California, Inc. Company Information

11.11.2 Pacific Biosciences of California, Inc. Tumor Genomics Product Offered

11.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Pacific Biosciences of California, Inc. Main Business Overview

11.11.5 Pacific Biosciences of California, Inc. Latest Developments

11.12 PerkinElmer

11.12.1 PerkinElmer Company Information

11.12.2 PerkinElmer Tumor Genomics Product Offered

11.12.3 PerkinElmer Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 PerkinElmer Main Business Overview

11.12.5 PerkinElmer Latest Developments

11.13 QIAGEN

11.13.1 QIAGEN Company Information

11.13.2 QIAGEN Tumor Genomics Product Offered

11.13.3 QIAGEN Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 QIAGEN Main Business Overview

11.13.5 QIAGEN Latest Developments

11.14 Siemens Healthineers AG

11.14.1 Siemens Healthineers AG Company Information

11.14.2 Siemens Healthineers AG Tumor Genomics Product Offered

11.14.3 Siemens Healthineers AG Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Siemens Healthineers AG Main Business Overview

11.14.5 Siemens Healthineers AG Latest Developments

11.15 Thermo Fisher Scientific Inc.

11.15.1 Thermo Fisher Scientific Inc. Company Information

11.15.2 Thermo Fisher Scientific Inc. Tumor Genomics Product Offered

11.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Thermo Fisher Scientific Inc. Main Business Overview

11.15.5 Thermo Fisher Scientific Inc. Latest Developments

12 Research Findings and Conclusion

Table 1. Tumor Genomics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Assays and Kits

Table 3. Major Players of Instrument

Table 4. Tumor Genomics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Tumor Genomics Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Tumor Genomics Market Size Market Share by Type (2017-2022)

Table 7. Tumor Genomics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Tumor Genomics Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Tumor Genomics Market Size Market Share by Application (2017-2022)

Table 10. Global Tumor Genomics Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Tumor Genomics Revenue Market Share by Player (2020-2022)

Table 12. Tumor Genomics Key Players Head office and Products Offered

Table 13. Tumor Genomics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Tumor Genomics Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Tumor Genomics Market Size Market Share by Regions (2017-2022)

Table 18. Americas Tumor Genomics Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Tumor Genomics Market Size Market Share by Country (2017-2022)

Table 20. Americas Tumor Genomics Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Tumor Genomics Market Size Market Share by Type (2017-2022)

Table 22. Americas Tumor Genomics Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Tumor Genomics Market Size Market Share by Application (2017-2022)

Table 24. APAC Tumor Genomics Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Tumor Genomics Market Size Market Share by Region (2017-2022)

Table 26. APAC Tumor Genomics Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Tumor Genomics Market Size Market Share by Type (2017-2022)

Table 28. APAC Tumor Genomics Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Tumor Genomics Market Size Market Share by Application (2017-2022)

Table 30. Europe Tumor Genomics Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Tumor Genomics Market Size Market Share by Country (2017-2022)

Table 32. Europe Tumor Genomics Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Tumor Genomics Market Size Market Share by Type (2017-2022)

Table 34. Europe Tumor Genomics Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Tumor Genomics Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Tumor Genomics Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Tumor Genomics Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Tumor Genomics Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Tumor Genomics Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Tumor Genomics Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Tumor Genomics Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Tumor Genomics

Table 43. Key Market Challenges & Risks of Tumor Genomics

Table 44. Key Industry Trends of Tumor Genomics

Table 45. Global Tumor Genomics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Tumor Genomics Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Tumor Genomics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Tumor Genomics Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Tumor Genomics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Tumor Genomics Market Size Market Share Forecast by Application (2023-2028)

Table 51. Abbott Laboratories Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 52. Abbott Laboratories Tumor Genomics Product Offered

Table 53. Abbott Laboratories Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Abbott Laboratories Main Business

Table 55. Abbott Laboratories Latest Developments

Table 56. Agilent Technologies, Inc Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 57. Agilent Technologies, Inc Tumor Genomics Product Offered

Table 58. Agilent Technologies, Inc Main Business

Table 59. Agilent Technologies, Inc Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Agilent Technologies, Inc Latest Developments

Table 61. Bio-Rad Laboratories, Inc. Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 62. Bio-Rad Laboratories, Inc. Tumor Genomics Product Offered

Table 63. Bio-Rad Laboratories, Inc. Main Business

Table 64. Bio-Rad Laboratories, Inc. Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Bio-Rad Laboratories, Inc. Latest Developments

Table 66. Danaher Corporation Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 67. Danaher Corporation Tumor Genomics Product Offered

Table 68. Danaher Corporation Main Business

Table 69. Danaher Corporation Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Danaher Corporation Latest Developments

Table 71. F. Hoffmann-La Roche Ltd Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 72. F. Hoffmann-La Roche Ltd Tumor Genomics Product Offered

Table 73. F. Hoffmann-La Roche Ltd Main Business

Table 74. F. Hoffmann-La Roche Ltd Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. F. Hoffmann-La Roche Ltd Latest Developments

Table 76. Fluidigm Corporation Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 77. Fluidigm Corporation Tumor Genomics Product Offered

Table 78. Fluidigm Corporation Main Business

Table 79. Fluidigm Corporation Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Fluidigm Corporation Latest Developments

Table 81. General Electric Company Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 82. General Electric Company Tumor Genomics Product Offered

Table 83. General Electric Company Main Business

Table 84. General Electric Company Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. General Electric Company Latest Developments

Table 86. Illumina, Inc. Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 87. Illumina, Inc. Tumor Genomics Product Offered

Table 88. Illumina, Inc. Main Business

Table 89. Illumina, Inc. Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Illumina, Inc. Latest Developments

Table 91. Merck KGaA Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 92. Merck KGaA Tumor Genomics Product Offered

Table 93. Merck KGaA Main Business

Table 94. Merck KGaA Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Merck KGaA Latest Developments

Table 96. Myriad Genetics, Inc. Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 97. Myriad Genetics, Inc. Tumor Genomics Product Offered

Table 98. Myriad Genetics, Inc. Main Business

Table 99. Myriad Genetics, Inc. Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Myriad Genetics, Inc. Latest Developments

Table 101. Pacific Biosciences of California, Inc. Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 102. Pacific Biosciences of California, Inc. Tumor Genomics Product Offered

Table 103. Pacific Biosciences of California, Inc. Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Pacific Biosciences of California, Inc. Main Business

Table 105. Pacific Biosciences of California, Inc. Latest Developments

Table 106. PerkinElmer Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 107. PerkinElmer Tumor Genomics Product Offered

Table 108. PerkinElmer Main Business

Table 109. PerkinElmer Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. PerkinElmer Latest Developments

Table 111. QIAGEN Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 112. QIAGEN Tumor Genomics Product Offered

Table 113. QIAGEN Main Business

Table 114. QIAGEN Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. QIAGEN Latest Developments

Table 116. Siemens Healthineers AG Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 117. Siemens Healthineers AG Tumor Genomics Product Offered

Table 118. Siemens Healthineers AG Main Business

Table 119. Siemens Healthineers AG Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Siemens Healthineers AG Latest Developments

Table 121. Thermo Fisher Scientific Inc. Details, Company Type, Tumor Genomics Area Served and Its Competitors

Table 122. Thermo Fisher Scientific Inc. Tumor Genomics Product Offered

Table 123. Thermo Fisher Scientific Inc. Main Business

Table 124. Thermo Fisher Scientific Inc. Tumor Genomics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Thermo Fisher Scientific Inc. Latest Developments

List of Figures

Figure 1. Tumor Genomics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Tumor Genomics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Tumor Genomics Market Size Market Share by Type in 2021

Figure 7. Tumor Genomics in Diagnostics and Monitoring

Figure 8. Global Tumor Genomics Market: Diagnostics and Monitoring (2017-2022) & ($ Millions)

Figure 9. Tumor Genomics in Drug Discovery and Development

Figure 10. Global Tumor Genomics Market: Drug Discovery and Development (2017-2022) & ($ Millions)

Figure 11. Tumor Genomics in Biomarker Discovery

Figure 12. Global Tumor Genomics Market: Biomarker Discovery (2017-2022) & ($ Millions)

Figure 13. Global Tumor Genomics Market Size Market Share by Application in 2021

Figure 14. Global Tumor Genomics Revenue Market Share by Player in 2021

Figure 15. Global Tumor Genomics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Tumor Genomics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Tumor Genomics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Tumor Genomics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Tumor Genomics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Tumor Genomics Value Market Share by Country in 2021

Figure 21. Americas Tumor Genomics Consumption Market Share by Type in 2021

Figure 22. Americas Tumor Genomics Market Size Market Share by Application in 2021

Figure 23. United States Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Tumor Genomics Market Size Market Share by Region in 2021

Figure 28. APAC Tumor Genomics Market Size Market Share by Application in 2021

Figure 29. China Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Tumor Genomics Market Size Market Share by Country in 2021

Figure 36. Europe Tumor Genomics Market Size Market Share by Type in 2021

Figure 37. Europe Tumor Genomics Market Size Market Share by Application in 2021

Figure 38. Germany Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Tumor Genomics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Tumor Genomics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Tumor Genomics Market Size Market Share by Application in 2021

Figure 46. Egypt Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Tumor Genomics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 55. United States Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 59. China Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 63. India Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 66. France Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 67. UK Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Tumor Genomics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Tumor Genomics Market Size 2023-2028 ($ Millions)